Formosa LaboratoriesTPE:4746 +1.29%70 EV-to-FCF is 18.33 as of Jul. 07, 2026, which is 37% above its 10-year median of 13.40. GuruFocus rates TPE:4746 with a GF Score™ of 70/100 and a GF Value™ of NT$98.98 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 564 Drug Manufacturers companies, Formosa Laboratories ranks better than 56.91% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Formosa Laboratories's Enterprise Value is NT$8,655 Mil.
Formosa Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$472 Mil. Therefore, Formosa Laboratories's EV-to-FCF for today is 18.33.
The historical rank and industry rank for Formosa Laboratories's EV-to-FCF or its related term are showing as below:
TPE:4746'
s EV-to-FCF Range Over the Past 10 Years
Min: -161.13 Med: 13.4 Max: 163.76
Current: 18.15
During the past 13 years, the highest EV-to-FCF of Formosa Laboratories was 163.76. The lowest was -161.13. And the median was 13.40.
TPE:4746's EV-to-FCF is ranked better than 56.91% of 564
companies
in the Drug Manufacturers industry
Industry Median: 20.75
vs TPE:4746: 18.15
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Formosa Laboratories's PE Ratio (TTM) for today is calculated as:
Formosa Laboratories's share price for today is NT$55.10.
Formosa Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.640.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Formosa Laboratories EV-to-FCF Related Terms
Formosa Laboratories EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Formosa Laboratories's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Formosa Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Formosa Laboratories EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Formosa Laboratories's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Formosa Laboratories's EV-to-FCF falls into.
Formosa Laboratories's current Enterprise Value is NT$8,655 Mil.
Formosa Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$472 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Formosa Laboratories (TPE:4746) has a EV-to-FCF of 18.33 as of Jul. 07, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Formosa Laboratories and its competitors. This is 37% above median its historical median of 13.40. According to the industry distribution chart, Formosa Laboratories ranks #243 out of 564 companies in the Drug Manufacturers industry, placing it in the top 43.1%.
Is Formosa Laboratories' EV-to-FCF too high?
Formosa Laboratories' current EV-to-FCF of 18.33 is 37% above median its 10-year median of 13.40. The Drug Manufacturers industry median EV-to-FCF is 20.75. Formosa Laboratories' value of 18.33 is 11.7% below this industry median. Based on the distribution chart, Formosa Laboratories ranks #243 out of 564 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Formosa Laboratories has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Formosa Laboratories' EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Formosa Laboratories ranks #243 out of 564 companies for EV-to-FCF. This puts Formosa Laboratories in the upper half of its industry. The industry median EV-to-FCF is 20.75. Formosa Laboratories' value of 18.33 is 11.7% below this benchmark. While the company's 10-year median is 13.40 vs. the industry median of 20.75, Formosa Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.75, based on 564 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Formosa Laboratories's current EV-to-FCF of 18.33 is 11.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Formosa Laboratories and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Formosa Laboratories's current EV-to-FCF is 18.33, which is 37% above median its own 10-year median of 13.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Formosa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Formosa Laboratories (TPE:4746) is currently considered Possible Value Trap. The stock's GF Value™ is NT$98.98, compared to a current price of NT$55.10 — trading 44.3% below its estimated fair value. The current EV-to-FCF is 18.33, which is 37% above median its 10-year median of 13.40 and 11.7% below the Drug Manufacturers industry median of 20.75. Formosa Laboratories' overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Formosa Laboratories (TPE:4746), the current EV-to-FCF is 18.33 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Formosa Laboratories (TPE:4746) Overvalued in 2026?
Based on GuruFocus' analysis, Formosa Laboratories stock appears to be undervalued.
The current stock price of NT$55.10 is trading 44.3% below its estimated GF Value™ of NT$98.98.
GuruFocus considers Formosa Laboratories to be Possible Value Trap.
Key valuation signals for TPE:4746:
EV-to-FCF: 18.33 (37% above median its 10-year median of 13.40)
GF Value™: NT$98.98 vs. price of NT$55.10 (44.3% below fair value)
Industry Position: 11.7% below the Drug Manufacturers median (#243 of 564)
No single metric tells the full story. See the TPE:4746 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Formosa Laboratories Inc is mainly engaged in the wholesale and manufacturing of active pharmaceutical ingredients, as well as ultraviolet absorbers. The company geographically operates in India, Taiwan, Netherlands, Switzerland, Germany, Japan, China, Canada, United States, and Others.
70GF Score
Get the complete analysis for TPE:4746
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4746 has been successfully added to your 
